MapLight Therapeutics MPLT
NASDAQ MPLT
$13.77 +0.63 (+4.79%)
At close: Sep 4, 2026 · 4:00 PM EDT

MapLight Therapeutics (MPLT) Amortizatization of Intangibles (2024 - 2025)

MapLight Therapeutics (MPLT) posted Amortizatization of Intangibles of $1.4 million for Q4 2025, up 252.57% sequentially from $409000.0 in Q4 2024, and up 252.57% YoY from $409000.0 in Q4 2024.

Analysis

MapLight Therapeutics (MPLT) Amortizatization of Intangibles (2024 - 2025) Analysis & Trends

MapLight Therapeutics has reported Amortizatization of Intangibles for 2 years, with the latest figure at $1.4 million in Q4 2025.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 MapLight Therapeutics 642.40 Mn 642.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.44 Mn
Sep 30, 2025 464,000.00
Dec 31, 2024 409,000.00